Boothbay Fund Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-37,500
Closed -$6.22M 1627
2025
Q1
$6.22M Buy
+37,500
New +$5.87M 0.16% 173
2023
Q1
Sell
-24,600
Closed -$4.35M 2327
2022
Q4
$4.35M Buy
24,600
+21,500
+694% +$3.71M 0.1% 280
2022
Q3
$506K Buy
3,100
+300
+11% +$50.8K 0.01% 1225
2022
Q2
$497K Sell
2,800
-6,600
-70% -$1.18M 0.01% 1179
2022
Q1
$1.67M Buy
+9,400
New +$1.6M 0.04% 653

Other funds holding JNJ

Boothbay Fund Management's JNJ Position: Q1 2026 in Review

Boothbay Fund Management reduced its Johnson & Johnson (JNJ) stake by 74% in Q1 2026, selling an estimated $878K and leaving 1,331 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Boothbay Fund Management first reported a position in JNJ in Q1 2015 and has held it in 21 quarters since. The position peaked at $13.7M in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Boothbay Fund Management held 1,331 shares of Johnson & Johnson worth $325K as of Q1 2026.
  • Boothbay Fund Management sold 3,769 Johnson & Johnson shares in Q1 2026, an estimated $878K.
  • Johnson & Johnson made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1573 holding.
  • Boothbay Fund Management first reported a position in Johnson & Johnson in Q1 2015 and has held it in 21 quarters since.
  • Boothbay Fund Management's Johnson & Johnson position peaked at $13.7M in Q3 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.